These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36128278)

  • 1. The Burden of Cardiovascular Disease Attributable to Modifiable Risk Factors and Cost-effectiveness Analysis of IraPEN Program in the General Population of Iran.
    Mokhtari M; Khalil D; Farzadfar F; Daroudi R; Asadi-Lari M
    Med J Islam Repub Iran; 2022; 36():73. PubMed ID: 36128278
    [No Abstract]   [Full Text] [Related]  

  • 2. A cost-effectiveness analysis of risk-based intervention for prevention of cardiovascular diseases in IraPEN program: A modeling study.
    Jamshidi A; Daroudi R; Aas E; Khalili D
    Front Public Health; 2023; 11():1075277. PubMed ID: 36908421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incremental cost of implementing the world health organization Package of essential non-communicable (PEN) diseases interventions in Iran.
    Azmin M; Mohebi F; Yoosefi M; Ahmadi N; Shirazi S; Modirian M; Farzadfar F
    PLOS Glob Public Health; 2023; 3(2):e0000449. PubMed ID: 36962715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timely referral to health centers for the prevention of cardiovascular diseases: IraPEN national program.
    Hadavandsiri F; Khalili D; Mahdavi A; Afkar M; Ostovar A; Hashemi-Nazari SS; Derakhshan S
    Front Public Health; 2023; 11():1098312. PubMed ID: 37809007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of the burden of cardiovascular disease attributable to modifiable risk factors and cost-effectiveness analysis of preventative interventions to reduce this burden in Argentina.
    Rubinstein A; Colantonio L; Bardach A; Caporale J; Martí SG; Kopitowski K; Alcaraz A; Gibbons L; Augustovski F; Pichón-Rivière A
    BMC Public Health; 2010 Oct; 10():627. PubMed ID: 20961456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cost-effectiveness analysis of a program to control rheumatic fever and rheumatic heart disease in Pinar del Rio, Cuba.
    Watkins DA; Mvundura M; Nordet P; Mayosi BM
    PLoS One; 2015; 10(3):e0121363. PubMed ID: 25768008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
    Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R
    Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agreement between Framingham, IraPEN and non-laboratory WHO-EMR risk score calculators for cardiovascular risk prediction in a large Iranian population.
    Mirzaei M; Mirzaei M
    J Cardiovasc Thorac Res; 2020; 12(1):20-26. PubMed ID: 32211134
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling study.
    Ortegón M; Lim S; Chisholm D; Mendis S
    BMJ; 2012 Mar; 344():e607. PubMed ID: 22389337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and treatment of cardiovascular disease in Ethiopia: a cost-effectiveness analysis.
    Tolla MT; Norheim OF; Memirie ST; Abdisa SG; Ababulgu A; Jerene D; Bertram M; Strand K; Verguet S; Johansson KA
    Cost Eff Resour Alloc; 2016; 14():10. PubMed ID: 27524939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breastfeeding promotion and priority setting in health.
    Horton S; Sanghvi T; Phillips M; Fiedler J; Perez-Escamilla R; Lutter C; Rivera A; Segall-Correa AM
    Health Policy Plan; 1996 Jun; 11(2):156-68. PubMed ID: 10158457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
    Yu J; Shah BM; Ip EJ; Chan J
    J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular disease burden attributable to dietary risk factors from 1990 to 2019: A systematic analysis of the Global Burden of Disease study.
    Dong C; Bu X; Liu J; Wei L; Ma A; Wang T
    Nutr Metab Cardiovasc Dis; 2022 Apr; 32(4):897-907. PubMed ID: 35067445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of web-based programs on the reduction of childhood obesity in school-aged children: A systematic review.
    Antwi F; Fazylova N; Garcon MC; Lopez L; Rubiano R; Slyer JT
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-14. PubMed ID: 27820152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis of the introduction of rotavirus vaccine in Iran.
    Javanbakht M; Moradi-Lakeh M; Yaghoubi M; Esteghamati A; Mansour Ghanaie R; Mahmoudi S; Shamshiri AR; Zahraei SM; Baxter L; Shakerian S; Chaudhri I; Fleming JA; Munier A; Baradaran HR
    Vaccine; 2015 May; 33 Suppl 1():A192-200. PubMed ID: 25919160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost Effectiveness of Implementing Integrated Management of Neonatal and Childhood Illnesses Program in District Faridabad, India.
    Prinja S; Bahuguna P; Mohan P; Mazumder S; Taneja S; Bhandari N; van den Hombergh H; Kumar R
    PLoS One; 2016; 11(1):e0145043. PubMed ID: 26727369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of medical primary prevention strategies to reduce absolute risk of cardiovascular disease in Tanzania: a Markov modelling study.
    Ngalesoni FN; Ruhago GM; Mori AT; Robberstad B; Norheim OF
    BMC Health Serv Res; 2016 May; 16():185. PubMed ID: 27184802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disability-Adjusted Life-Years (DALYs) for 315 Diseases and Injuries and Healthy Life Expectancy (HALE) in Iran and its Neighboring Countries, 1990-2015: Findings from Global Burden of Disease Study 2015.
    Sepanlou SG; Parsaeian M; Krohn KJ; Afshin A; Farzadfar F; Roshandel G; Karimkhani C; Bazargan-Hejazi S; Kiadaliri AA; Ahmadieh H; Djalalinia S; Ebrahimi H; Eshrati B; Esteghamati AR; Farvid MS; Fereshtehnejad SM; Hafezi-Nejad N; Hassanvand MS; Heydarpour P; Islami F; Karimi SM; Katibeh M; Khosravi A; Khubchandani J; Mahdavi M; Pishgar F; Qorbani M; Rahimi-Movaghar V; Safi S; Sahraian MA; Shahraz S; Sheikhbahaei S; Mohammadi A; Mokdad AH; Vos T; Murray CJL; Moradi-Lakeh M; Naghavi M; Malekzadeh R
    Arch Iran Med; 2017 Jul; 20(7):403-418. PubMed ID: 28745902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in blood pressure among users of lay health worker or volunteer operated community-based blood pressure programs over time: a systematic review protocol.
    Skar P; Young L; Gordon C
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):30-40. PubMed ID: 26571280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing and predicting the trend of cardiovascular risk factors in 40-80-year population based on the Ira-PEN program as an integrated service in primary health care.
    Ezzati F; Jafarzadeh M; Darabi F
    J Educ Health Promot; 2023; 12():374. PubMed ID: 38144037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.